Mylan Nv
- All
- News
-
US Body Warns Pharma Firm Mylan Over Quality In Telangana Plant: Report
Mylan NV received a warning from US regulators for failing to ensure key drug ingredients made at one of its plants in India were not contaminated.
-
Mylan Pharma To Launch Remdesivir In India At Rs 4,800 Per 100 mg Vial
Drugmaker Mylan NV said on Monday it would launch its generic version of Gilead Sciences Inc's COVID-19 treatment remdesivir in India this month at 4,800 rupees ($64.31) per 100 mg vial, as infections surge in the world's third worst-hit country.
-
US Body Warns Pharma Firm Mylan Over Quality In Telangana Plant: Report
Mylan NV received a warning from US regulators for failing to ensure key drug ingredients made at one of its plants in India were not contaminated.
-
Mylan Pharma To Launch Remdesivir In India At Rs 4,800 Per 100 mg Vial
Drugmaker Mylan NV said on Monday it would launch its generic version of Gilead Sciences Inc's COVID-19 treatment remdesivir in India this month at 4,800 rupees ($64.31) per 100 mg vial, as infections surge in the world's third worst-hit country.
